| __timestamp | Dr. Reddy's Laboratories Limited | Grifols, S.A. |
|---|---|---|
| Wednesday, January 1, 2014 | 56369000000 | 1656170000 |
| Thursday, January 1, 2015 | 62786000000 | 2003565000 |
| Friday, January 1, 2016 | 62427000000 | 2137539000 |
| Sunday, January 1, 2017 | 62453000000 | 2166062000 |
| Monday, January 1, 2018 | 65724000000 | 2437164000 |
| Tuesday, January 1, 2019 | 70421000000 | 2757459000 |
| Wednesday, January 1, 2020 | 80591000000 | 3084873000 |
| Friday, January 1, 2021 | 86645000000 | 2970522000 |
| Saturday, January 1, 2022 | 100551000000 | 3832437000 |
| Sunday, January 1, 2023 | 42907000000 | 4269276000 |
| Monday, January 1, 2024 | 115557000000 |
Unveiling the hidden dimensions of data
In the competitive landscape of pharmaceuticals, cost efficiency is paramount. Dr. Reddy's Laboratories Limited and Grifols, S.A. have been pivotal players in this arena. Over the past decade, Dr. Reddy's has consistently demonstrated a robust cost of revenue, peaking in 2024 with a staggering 115% increase from 2014. In contrast, Grifols, S.A. has shown a steady, albeit modest, growth of approximately 158% over the same period.
From 2014 to 2023, Dr. Reddy's Laboratories saw fluctuations, with a notable dip in 2023, while Grifols maintained a more stable trajectory. The data reveals a missing value for Grifols in 2024, indicating potential reporting delays or strategic shifts. This comparison underscores the diverse strategies employed by these pharmaceutical giants in managing their cost structures, reflecting broader industry trends and economic conditions.
Comparing Cost of Revenue Efficiency: Pfizer Inc. vs Dr. Reddy's Laboratories Limited
Sanofi vs Grifols, S.A.: Efficiency in Cost of Revenue Explored
Cost of Revenue: Key Insights for Viatris Inc. and Grifols, S.A.
Cost of Revenue Comparison: Dr. Reddy's Laboratories Limited vs Walgreens Boots Alliance, Inc.
Dr. Reddy's Laboratories Limited and Grifols, S.A.: A Detailed Gross Profit Analysis
Cost of Revenue: Key Insights for Dr. Reddy's Laboratories Limited and Supernus Pharmaceuticals, Inc.
Comparing Cost of Revenue Efficiency: Dr. Reddy's Laboratories Limited vs Xencor, Inc.
Dr. Reddy's Laboratories Limited vs Viridian Therapeutics, Inc.: Efficiency in Cost of Revenue Explored
Analyzing Cost of Revenue: Pharming Group N.V. and Grifols, S.A.
Cost of Revenue Trends: Grifols, S.A. vs Corcept Therapeutics Incorporated
Analyzing Cost of Revenue: Grifols, S.A. and Agios Pharmaceuticals, Inc.
Cost of Revenue Comparison: Grifols, S.A. vs Celldex Therapeutics, Inc.